Almoosa Health Company (TADAWUL:4018)
Saudi Arabia
· Delayed Price · Currency is SAR 174.60
+0.90 (0.52%)
Aug 14, 2025, 3:17 PM AST
Almoosa Health Company Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 1,313 | 1,202 | 978.97 | 816.04 | 701.54 | 628.97 |
| Revenue Growth (YoY) | - | 22.82% | 19.97% | 16.32% | 11.54% | - |
| Cost of Revenue | 887.12 | 834.02 | 674.5 | 587.73 | 486.9 | 408.79 |
| Gross Profit | 425.42 | 368.32 | 304.47 | 228.31 | 214.64 | 220.17 |
| Selling, General & Admin | 207.25 | 200.05 | 190.33 | 172.75 | 147.89 | 113.81 |
| Other Operating Expenses | -15.02 | -18.22 | -13.82 | - | - | - |
| Operating Expenses | 195.93 | 186.23 | 180.44 | 172.75 | 147.89 | 113.81 |
| Operating Income | 229.49 | 182.09 | 124.03 | 55.56 | 66.75 | 106.36 |
| Interest Expense | -49.53 | -80.53 | -22.59 | -15.38 | -3.82 | -3.02 |
| Earnings From Equity Investments | 0.89 | 1.19 | - | - | - | - |
| Other Non Operating Income (Expenses) | -0.1 | - | - | 15.36 | 9.03 | 5.64 |
| EBT Excluding Unusual Items | 187.44 | 102.74 | 101.45 | 55.54 | 71.96 | 108.99 |
| Gain (Loss) on Sale of Assets | 0.11 | 0.11 | 0.33 | 0.03 | -0.07 | 0 |
| Asset Writedown | - | - | - | -0.01 | -0.01 | -0.55 |
| Pretax Income | 187.55 | 102.85 | 101.78 | 55.56 | 71.88 | 108.44 |
| Income Tax Expense | 2.73 | 8.43 | 3.63 | 4.54 | 9.46 | 3.67 |
| Net Income | 184.82 | 94.42 | 98.15 | 51.02 | 62.42 | 104.77 |
| Net Income to Common | 184.82 | 94.42 | 98.15 | 51.02 | 62.42 | 104.77 |
| Net Income Growth | - | -3.79% | 92.38% | -18.27% | -40.42% | - |
| Shares Outstanding (Basic) | 44 | 35 | 35 | 35 | 0 | - |
| Shares Outstanding (Diluted) | 44 | 35 | 35 | 35 | 0 | - |
| Shares Change (YoY) | - | - | - | 34900.00% | - | - |
| EPS (Basic) | 4.17 | 2.70 | 2.80 | 1.46 | 624.20 | - |
| EPS (Diluted) | 4.17 | 2.70 | 2.80 | 1.46 | 624.20 | - |
| EPS Growth | - | -3.79% | 92.38% | -99.77% | - | - |
| Free Cash Flow | -117.36 | -56.66 | -343.12 | -318.15 | -120.76 | -286.89 |
| Free Cash Flow Per Share | -2.65 | -1.62 | -9.80 | -9.09 | -1207.55 | - |
| Dividend Per Share | - | 1.000 | - | - | - | - |
| Gross Margin | 32.41% | 30.63% | 31.10% | 27.98% | 30.59% | 35.00% |
| Operating Margin | 17.48% | 15.14% | 12.67% | 6.81% | 9.52% | 16.91% |
| Profit Margin | 14.08% | 7.85% | 10.03% | 6.25% | 8.90% | 16.66% |
| Free Cash Flow Margin | -8.94% | -4.71% | -35.05% | -38.99% | -17.21% | -45.61% |
| EBITDA | 308.25 | 257.04 | 182.72 | 105.45 | 88.99 | 129.3 |
| EBITDA Margin | 23.48% | 21.38% | 18.67% | 12.92% | 12.68% | 20.56% |
| D&A For EBITDA | 78.77 | 74.95 | 58.69 | 49.89 | 22.24 | 22.94 |
| EBIT | 229.49 | 182.09 | 124.03 | 55.56 | 66.75 | 106.36 |
| EBIT Margin | 17.48% | 15.14% | 12.67% | 6.81% | 9.52% | 16.91% |
| Effective Tax Rate | 1.45% | 8.19% | 3.57% | 8.17% | 13.16% | 3.38% |
| Advertising Expenses | - | 19.17 | 8.96 | 10.58 | 7.2 | 3.6 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.